Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,264 | 127 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $527.66 | 51 | $0 (2024) |
| GlaxoSmithKline, LLC. | $173.18 | 9 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $171.09 | 10 | $0 (2024) |
| Lilly USA, LLC | $170.00 | 7 | $0 (2024) |
| ViiV Healthcare Company | $156.84 | 9 | $0 (2022) |
| ABBVIE INC. | $146.60 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $139.68 | 6 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $117.21 | 4 | $0 (2023) |
| Astellas Pharma US Inc | $114.42 | 5 | $0 (2024) |
| Lexicon Pharmaceuticals, Inc. | $113.96 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $442.98 | 13 | Lexicon Pharmaceuticals, Inc. ($113.96) |
| 2023 | $1,139 | 65 | Novo Nordisk Inc ($369.25) |
| 2022 | $645.28 | 47 | ViiV Healthcare Company ($156.84) |
| 2021 | $37.16 | 2 | ARBOR PHARMACEUTICALS, INC. ($20.80) |
All Payment Transactions
127 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $33.67 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $31.98 | General |
| Category: Respiratory | ||||||
| 03/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $31.26 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Diabetes | ||||||
| 02/29/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $113.96 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 02/20/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $30.82 | General |
| Category: PSYCHIATRY | ||||||
| 02/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Obesity | ||||||
| 02/05/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 01/31/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $32.74 | General |
| Category: Biological | ||||||
| 01/26/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $34.76 | General |
| Category: Obesity | ||||||
| 01/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: DIABETES | ||||||
| 01/17/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: VACCINES | ||||||
| 01/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.46 | General |
| Category: PSYCHIATRY | ||||||
| 12/21/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: Diabetes | ||||||
| 12/18/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $28.64 | General |
| Category: PAIN | ||||||
| 12/12/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $26.37 | General |
| Category: PSYCHIATRY | ||||||
| 12/08/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $32.33 | General |
| Category: VACCINES | ||||||
| 12/06/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $5.87 | General |
| Category: Obesity | ||||||
| 11/29/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Diabetes | ||||||
| 11/28/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.61 | General |
| Category: Obesity | ||||||
| 11/20/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Diabetes | ||||||
| 11/16/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.23 | General |
| Category: Diabetes | ||||||
| 11/07/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.46 | General |
| Category: Diabetes | ||||||
| 11/02/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 14 | 17 | $10,889 | $1,259 |
| 2022 | 4 | 90 | 102 | $30,885 | $4,133 |
| 2021 | 5 | 124 | 150 | $42,724 | $5,439 |
| 2020 | 3 | 116 | 136 | $40,677 | $5,381 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 17 | $10,889 | $1,259 | 11.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 37 | 44 | $28,063 | $2,831 | 10.1% |
| 0004A | Adm sarscov2 30mcg/0.3ml bst | Office | 2022 | 19 | 20 | $520.00 | $517.42 | 99.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 20 | 24 | $1,938 | $422.53 | 21.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 14 | 14 | $364.00 | $362.48 | 99.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 33 | 44 | $30,108 | $2,646 | 8.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 54 | 67 | $5,360 | $1,421 | 26.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 11 | 13 | $1,547 | $731.37 | 47.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 13 | $5,150 | $539.25 | 10.5% |
| 98966 | Telephone assessment and management service, 5-10 minutes of medical discussion | Office | 2021 | 13 | 13 | $559.00 | $101.42 | 18.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 58 | 71 | $5,680 | $2,610 | 45.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 29 | 31 | $22,075 | $1,097 | 5.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 17 | 20 | $2,380 | $1,026 | 43.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 12 | 14 | $10,542 | $647.81 | 6.1% |
About Edna Yee, NURSE PRACTITIONER
Edna Yee, NURSE PRACTITIONER is a Family healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1205975497.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Edna Yee, NURSE PRACTITIONER has received a total of $2,264 in payments from pharmaceutical and medical device companies, with $442.98 received in 2024. These payments were reported across 127 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,264).
As a Medicare-enrolled provider, Yee has provided services to 344 Medicare beneficiaries, totaling 405 services with total Medicare billing of $16,212. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Family
- Location San Francisco, CA
- Active Since 02/05/2007
- Last Updated 09/30/2019
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1205975497
Products in Payments
- Rybelsus (Drug) $201.53
- Ozempic (Drug) $191.14
- APRETUDE (Biological) $156.84
- Inpefa (Drug) $113.96
- Wegovy (Drug) $111.53
- ZTLido (Drug) $110.30
- TRELEGY ELLIPTA (Drug) $92.61
- AUSTEDO (Drug) $90.08
- JARDIANCE (Drug) $87.65
- REXULTI (Drug) $84.65
- STIOLTO RESPIMAT (Drug) $83.44
- MOUNJARO (Drug) $74.53
- BREZTRI (Drug) $62.79
- Veozah (Drug) $59.42
- QULIPTA (Drug) $53.77
- SHINGRIX (Biological) $53.77
- UBRELVY (Drug) $47.62
- TRULICITY (Drug) $45.77
- FARXIGA (Drug) $44.91
- Myrbetriq (Drug) $38.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in San Francisco
Annika Ehrlich, Ms, Rn, Fnp-C, MS, RN, FNP-C
Family — Payments: $81,176
Dr. Orlando Harris, Np-F, NP-F
Family — Payments: $29,820
Ms. Christine Garvey, Fnp, FNP
Family — Payments: $22,466
Nadine Wlasiuk, Aprn,Cpnp-Pc, Fnp-Bc, APRN,CPNP-PC, FNP-BC
Family — Payments: $16,522
Christian Salinas
Family — Payments: $7,249
Alicia Chang, Np, NP
Family — Payments: $6,430